Versant Venture Management, LLC
CIK: 0001560009SEC EDGAR →
Portfolio Value
$151.1M
Holdings
7
As of
Q4 2025
New Positions
1
Closed Positions
0
Portfolio Value History
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Monte Rosa Therapeutics, Inc. | 4,382,687 | $68.7M | 45.49% |
| 2 | Lenz Therapeutics, Inc. | 2,656,888 | $42.5M | 28.14% |
| 3 | Jade Biosciences, Inc. | 1,525,820 | $23.5M | 15.59% |
| 4 | CRISPR Therapeutics AG | 148,831 | $7.8M | 5.17% |
| 5 | Contineum Therapeutics, Inc. | 542,628 | $6.2M | 4.11% |
| 6 | Skye Bioscience, Inc. | 2,007,704 | $1.5M | 1.00% |
| 7 | Tempest Therapeutics, Inc. | 269,772 | $774K | 0.51% |
Quarterly Changes
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 6 | $150.3M | 99.5% |
| Unknown | 1 | $774K | 0.5% |